MedTrace Logo

High Flow Nasal Oxygen for Exacerbation COPD

NCT06084117 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-08-21

No results posted yet for this study

Summary

In this pilot study the feasibility of performing a larger trial to study the non-inferiority of High Flow Nasal Oxygen compared to non-invasive ventilation in patients with acute acidotic hypercapnic exacerbation of COPD wil be investigated

Conditions

  • Acute Exacerbation of COPD

Interventions

OTHER

HFNO

Respiratory support with HFNO (as opposed to NIV, as per standard of care)

OTHER

NIV

Respiratory support with Non-invasive ventilation, standard of care

Sponsors & Collaborators

  • Reinier de Graaf Groep

    collaborator OTHER

  • Haga Medisch Centrum

    collaborator UNKNOWN

  • Ikazia Hospital, Rotterdam

    collaborator OTHER

  • Franciscus Gasthuis

    lead OTHER

Principal Investigators

  • Dorien Kiers, MD, PhD · Franciscus Gasthuis & Vlietland

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-14
Primary Completion
2026-09-01
Completion
2026-12-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06084117 on ClinicalTrials.gov